Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Piantelli

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parametersG Scambia, G Ferrandina, M Marone, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|May 4, 2001
Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastomaG Castrilli, M Piantelli, L Artese, et al.
Anti-Cancer Drugs|October 1, 1990
Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growthG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1987
Glucocorticoid receptors and corticosensitivity of human thymocytes at discrete stages of intrathymic differentiationF O Ranelletti, N Maggiano, F B Aiello, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1986
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptorsM Piantelli, L M Larocca, F B Aiello, et al.
Cancer Research|December 11, 1997
Methyl-p-hydroxyphenyllactate-esterase activity in breast cancer: a potentially new prognostic factor in short-term follow-upA Carbone, F G Serra, G Ferrandina, et al.
Journal of Clinical Pathology|December 1, 1990
Type II oestrogen binding sites in human colorectal carcinomaM Piantelli, R Ricci, L M Larocca, et al.
American Journal of Respiratory Cell and Molecular Biology|July 1, 1997
Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancerS Caltagirone, F O Ranelletti, A Rinelli, et al.
Cancer Letters|September 4, 1995
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS)G Ferrandina, F O Ranelletti, G Scambia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Oral ipriflavone (7-isopropoxy-isoflavone) treatment for elderly patients with resistant acute leukemiasL Pagano, L Teofili, L Mele, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parametersG Scambia, G Ferrandina, M Marone, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|May 4, 2001
Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastomaG Castrilli, M Piantelli, L Artese, et al.
Anti-Cancer Drugs|October 1, 1990
Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growthG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1987
Glucocorticoid receptors and corticosensitivity of human thymocytes at discrete stages of intrathymic differentiationF O Ranelletti, N Maggiano, F B Aiello, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1986
Proliferation of phenotypically immature human thymocytes with and without interleukin 2 receptorsM Piantelli, L M Larocca, F B Aiello, et al.
Cancer Research|December 11, 1997
Methyl-p-hydroxyphenyllactate-esterase activity in breast cancer: a potentially new prognostic factor in short-term follow-upA Carbone, F G Serra, G Ferrandina, et al.
Journal of Clinical Pathology|December 1, 1990
Type II oestrogen binding sites in human colorectal carcinomaM Piantelli, R Ricci, L M Larocca, et al.
American Journal of Respiratory Cell and Molecular Biology|July 1, 1997
Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancerS Caltagirone, F O Ranelletti, A Rinelli, et al.
Cancer Letters|September 4, 1995
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS)G Ferrandina, F O Ranelletti, G Scambia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
Oral ipriflavone (7-isopropoxy-isoflavone) treatment for elderly patients with resistant acute leukemiasL Pagano, L Teofili, L Mele, et al.
Pageof 14